A new trading day began on Monday, with Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) stock price up 7.56% from the previous day of trading, before settling in for the closing price of $0.62. IRWD’s price has ranged from $0.53 to $7.11 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -3.89% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 1644.75%. With a float of $155.78 million, this company’s outstanding shares have now reached $161.81 million.
In an organization with 253 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 99.69%, operating margin of 17.25%, and the pretax margin is 7.54%.
Ironwood Pharmaceuticals Inc (IRWD) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Ironwood Pharmaceuticals Inc is 3.73%, while institutional ownership is 96.62%. The most recent insider transaction that took place on May 16 ’25, was worth 7,745. In this transaction Chief Executive Officer of this company sold 13,353 shares at a rate of $0.58, taking the stock ownership to the 1,147,281 shares. Before that another transaction happened on May 16 ’25, when Company’s Chief Commercial Officer sold 2,563 for $0.58, making the entire transaction worth $1,487. This insider now owns 242,596 shares in total.
Ironwood Pharmaceuticals Inc (IRWD) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 1644.75% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 141.01% during the next five years compared to -47.49% drop over the previous five years of trading.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Trading Performance Indicators
Here are Ironwood Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.34. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.34. Likewise, its price to free cash flow for the trailing twelve months is 1.38.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.20, a number that is poised to hit 0.03 in the next quarter and is forecasted to reach 0.35 in one year’s time.
Technical Analysis of Ironwood Pharmaceuticals Inc (IRWD)
Let’s dig in a bit further. During the last 5-days, its volume was 4.19 million. That was better than the volume of 3.37 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 30.85%. Additionally, its Average True Range was 0.09.
During the past 100 days, Ironwood Pharmaceuticals Inc’s (IRWD) raw stochastic average was set at 3.99%, which indicates a significant decrease from 36.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 160.71% in the past 14 days, which was higher than the 138.60% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7611, while its 200-day Moving Average is $2.7343. However, in the short run, Ironwood Pharmaceuticals Inc’s stock first resistance to watch stands at $0.7096. Second resistance stands at $0.7523. The third major resistance level sits at $0.7971. If the price goes on to break the first support level at $0.6221, it is likely to go to the next support level at $0.5773. The third support level lies at $0.5346 if the price breaches the second support level.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Key Stats
With a market capitalization of 107.92 million, the company has a total of 161,820K Shares Outstanding. Currently, annual sales are 351,410 K while annual income is 880 K. The company’s previous quarter sales were 41,140 K while its latest quarter income was -37,390 K.
